Conference Report

2008 International Symposium on Supportive Care in Cancer: Conference Report

Source: CCO Independent Conference Coverage of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology 2008 International Symposium*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

2008 International Symposium on Supportive Care in Cancer: Conference Report


Faculty:

Matti S. Aapro, MDEduardo Bruera, MD
  • Matti S. Aapro, MD
  • Eduardo Bruera, MD

CME CREDIT INFORMATION

Release Date: 10/14/08

Expiration Date: 10/13/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credits

Status: Please log in to view status


Begin the Conference Report

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the role of rash in the treatment of cancer with agents targeting the epidermal growth factor receptor
  • Identify strategies to prevent or reduce chemotherapy-induced nausea and vomiting
  • Discuss the role of inflammation in symptom complexes in cancer patients
  • Explain current changes in the use of erythropoiesis-stimulating agents in the setting of cancer therapy

Topics covered include:

  • Adverse Skin Reactions Associated With Targeted Therapy
  • Use of Casopitant for Prevention of Nausea and Vomiting in Moderately and Highly Emetogenic Chemotherapy
  • Cytokine-Associated Proinflammatory Symptoms
  • Effect of Reduced Use of Erythropoiesis-Stimulating Agents on Transfusion Resources
  • Alcoholism Screening in Patients With Advanced Cancer
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.